Patents by Inventor Glenn Cooper
Glenn Cooper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11976215Abstract: Solutions to the problems of scuffing and chipping of the paint films in high traffic areas and in tight spaces, such as dressing rooms in department stores, where multiple scrapings of the wall paints are created by consumers, clothes hangers, shoes, etc., and hallways and conference rooms in office and other commercial buildings are disclosed. Wax seeded latex polymers admixed with an added wax in architectural compositions and optionally with polyurethane resin are utilized to create paint films that are resistant to scuffing and chipping.Type: GrantFiled: January 20, 2022Date of Patent: May 7, 2024Assignee: Columbia Insurance CompanyInventors: Jonathan Dugan, Ashlee Agens, Ed Ament, Glenn Cooper, Johanna Garcia, Jeff Hood, Kevin Lee, Kate O'Connor, Rogina Saad, Marie Saturne, Jeffrey T. Spillane
-
Publication number: 20220135808Abstract: Solutions to the problems of scuffing and chipping of the paint films in high traffic areas and in tight spaces, such as dressing rooms in department stores, where multiple scrapings of the wall paints are created by consumers, clothes hangers, shoes, etc., and hallways and conference rooms in office and other commercial buildings are disclosed. Wax seeded latex polymers admixed with an added wax in architectural compositions and optionally with polyurethane resin are utilized to create paint films that are resistant to scuffing and chipping.Type: ApplicationFiled: January 20, 2022Publication date: May 5, 2022Inventors: Jonathan Dugan, Ashlee Agens, Ed Ament, Glenn Cooper, Johanna Garcia, Jeff Hood, Kevin Lee, Kate O'Connor, Rogina Saad, Marie Saturne, Jeffrey T. Spillane
-
Patent number: 11230645Abstract: Solutions to the problems of scuffing and chipping of the paint films in high traffic areas and in tight spaces, such as dressing rooms in department stores, where multiple scrapings of the wall paints are created by consumers, clothes hangers, shoes, etc., and hallways and conference rooms in office and other commercial buildings are disclosed. Wax seeded latex polymers admixed with an added wax in architectural compositions and optionally with polyurethane resin are utilized to create paint films that are resistant to scuffing and chipping.Type: GrantFiled: May 5, 2017Date of Patent: January 25, 2022Assignee: Columbia Insurance CompanyInventors: Jonathan Dugan, Ashlee Agens, Ed Ament, Glenn Cooper, Johanna Garcia, Jeff Hood, Kevin Lee, Kate O'Connor, Rogina Saad, Marie Saturne, Jeffrey T. Spillane
-
Publication number: 20210387227Abstract: A thin highly-open fabric or sleeve is placed over a paint roller cover, allowing the flow of paint in and out of the roller cover and smoother paint films.Type: ApplicationFiled: December 10, 2019Publication date: December 16, 2021Inventors: Glenn COOPER, Gary DANDREAUX, William SOMERS, Clarena SHAVEL, Stefanie IANNACONE, Dimitri ZAFIROGLU, Rita DESAI
-
Publication number: 20190144685Abstract: Solutions to the problems of scuffing and chipping of the paint films in high traffic areas and in tight spaces, such as dressing rooms in department stores, where multiple scrapings of the wall paints are created by consumers, clothes hangers, shoes, etc., and hallways and conference rooms in office and other commercial buildings are disclosed. Wax seeded latex polymers admixed with an added wax in architectural compositions and optionally with polyurethane resin are utilized to create paint films that are resistant to scuffing and chipping.Type: ApplicationFiled: May 5, 2017Publication date: May 16, 2019Inventors: Jonathan Dugan, Ashlee Agens, Ed Ament, Glenn Cooper, Johanna Garcia, Jeff Hood, Kevin Lee, Kate O'Connor, Rogina Saad, Marie Saturne, Jeff Spillane
-
Patent number: 10040966Abstract: The present invention is directed to an aqueous architectural composition comprising a low Tg (less than about ?10° C. and higher than about ?50° C.) acrylic emulsion polymer with at least one cross-linkable moiety, and solid polyutherane (PU) or polybutylacrylate microspheres having a mean weight diameter of less than about 40 microns and a Tg of less than about 0° C., wherein the solid PU spheres make up about 10% to about 20% by weight of the composition. The solid acrylic polymer without water and the PU spheres make up about 30% to about 40% by weight of the aqueous composition. A dried paint film formed by the inventive aqueous architectural composition can withstand at least about 500 cycles on the scrub test, and a gloss value at 60° of less than about 2.5 GU.Type: GrantFiled: May 6, 2016Date of Patent: August 7, 2018Assignee: Columbia Insurance CompanyInventors: Yong Yang, Glenn Cooper, Robert Sheerin, Johanna Garcia, Clarena Shavel
-
Publication number: 20170321078Abstract: The present invention is directed to an aqueous architectural composition comprising a low Tg (less than about ?10° C. and higher than about ?50° C.) acrylic emulsion polymer with at least one cross-linkable moiety, and solid polyutherane (PU) or polybutylacrylate microspheres having a mean weight diameter of less than about 40 microns and a Tg of less than about 0° C., wherein the solid PU spheres make up about 10% to about 20% by weight of the composition. The solid acrylic polymer without water and the PU spheres make up about 30% to about 40% by weight of the aqueous composition. A dried paint film formed by the inventive aqueous architectural composition can withstand at least about 500 cycles on the scrub test, and a gloss value at 60° of less than about 2.5 GU.Type: ApplicationFiled: May 6, 2016Publication date: November 9, 2017Inventors: Yong Yang, Glenn Cooper, Robert Sheerin, Johanna Garcia, Clarena Shavel
-
Patent number: 9040617Abstract: Water-borne cross-linking polymeric compositions and related embodiments, such as methods of making and using the compositions, as well as products formed with said compositions are described. The water-borne composition may comprise one or more polymers formulated from one or more monomers of which at least one is a monomer that yields acetaldehyde as a hydrolysis product, and incorporating cross-linking functionality such as, but not limited to, carbonyl or epoxy functionality, and a blocked cross-linking agent, for example, a hydrazone. Neither the cross-linking functionality nor the acetaldehyde reacts with the blocked cross-linking agent; however, the blocked cross-linking agent is capable of conversion to an alternative form cross-linking agent such as, but not limited to, a hydrazide, to yield a cross-linked polymer. The alternative form cross-linking agent may be formed in an equilibrium reaction including the blocked cross-linking agent.Type: GrantFiled: February 8, 2013Date of Patent: May 26, 2015Assignee: Columbia Insurance Company, Inc.Inventors: Yong Yang, Johanna L. Garcia de Visicaro, Robert Sheerin, Steve Minassian, Glenn Cooper
-
Publication number: 20140228509Abstract: Water-borne cross-linking polymeric compositions and related embodiments, such as methods of making and using the compositions, as well as products formed with said compositions are described. The water-borne composition may comprise one or more polymers formulated from one or more monomers of which at least one is a monomer that yields acetaldehyde as a hydrolysis product, and incorporating cross-linking functionality such as, but not limited to, carbonyl or epoxy functionality, and a blocked cross-linking agent, for example, a hydrazone. Neither the cross-linking functionality nor the acetaldehyde reacts with the blocked cross-linking agent; however, the blocked cross-linking agent is capable of conversion to an alternative form cross-linking agent such as, but not limited to, a hydrazide, to yield a cross-linked polymer. The alternative form cross-linking agent may be formed in an equilibrium reaction including the blocked cross-linking agent.Type: ApplicationFiled: February 8, 2013Publication date: August 14, 2014Applicant: COLUMBIA INSURANCE COMPANYInventors: YONG YANG, JOHANNA L. GARCIA DE VISICARO, ROBERT SHEERIN, STEVE MINASSIAN, GLENN COOPER
-
Publication number: 20060217405Abstract: An anti-muscarinic agent exemplified by trospium is administered by intravesicular instillation into the bladder and used to treat interstitial cystitis. The instilled medication does not interact systemically with the patient; the localized effect of the medication avoids any question of systemic side effects or untoward reactions with body organs or systems.Type: ApplicationFiled: March 16, 2006Publication date: September 28, 2006Inventors: Bobby Sandage, Glenn Cooper
-
Publication number: 20060128794Abstract: The present invention relates to non-psychoactive derivatives of tetrahydrocannabinol, which are useful in treating interstitial cystitis and relieving symptoms thereof. The invention uses (6aR,10aR)-?8-tetrahydrocannabinol-11-oic acids (hereinafter referred to as (6aR,10aR)-?8-THC-11-oic acid), as well as pharmaceutical compositions containing the (6aR,10aR)-?8-THC-11-oic acids, for treatment of interstitial cystitis in a mammal. The invention further covers methods of formulating and administering the compounds and pharmaceutical compositions as therapeutic agents in the treatment of interstitial cystitis, with particularly preferred administration routes being oral and via intravesicular instillation.Type: ApplicationFiled: December 13, 2005Publication date: June 15, 2006Applicant: Indevus Pharmaceuticals, Inc.Inventors: Bobby Sandage, Glenn Cooper
-
Publication number: 20060128738Abstract: The present invention relates to non-psychoactive derivatives of tetrahydrocannabinol, which are useful in treating interstitial cystitis and relieving symptoms thereof. The invention uses cannabinol analogs, which are preferably analogs of (6aR,10aR)-?8-tetrahydrocannabinol-11-oic acids [hereinafter referred to as (6aR,10aR)-?8-THC-11-oic acid], as well as pharmaceutical compositions containing the cannabinol analogs and analogs of (6aR,10aR)-?8-THC-11-oic acids, for treatment of interstitial cystitis in a mammal. The invention further covers methods of formulating and administering the compounds and pharmaceutical compositions as therapeutic agents in the treatment of interstitial cystitis, with particularly preferred administration routes being oral and via intravesicular instillation.Type: ApplicationFiled: December 13, 2005Publication date: June 15, 2006Applicant: Indevus Pharmaceuticals, Inc.Inventors: Bobby Sandage, Glenn Cooper